Simple Summary This review aims to shed light on the proliferative markers important in the
everyday clinical management of colorectal cancer (CRC), ranging from simple methods of …

Recent studies suggested that prolyl hydroxylase 2 (PHD2) functions as an important
regulator in vascular inflammation and Streptococcus pneumonia infection. However …

BACKGROUND: Little information exists on Kras mutations and p53 overexpression in
pseudomyxoma peritonei (PMP). These genetic alterations are associated with poorer …

Background: Conflicting results have been reported about the association between the Ki67
labeling index (Ki67-Li) and clinical outcome in patients with colorectal cancer (CRC) …

Background: CDX2 is a caudal homeobox gene essential for intestinal differentiation and is
specifically expressed in colorectal adenocarcinomas. Its role in colorectal carcinogenesis is …

Aim To establish a correlation between overexpression of p53 with the clinical features,
tumour histopathology and stage of Colorectal Carcinoma (CRC). Materials and Methods …

Colorectal cancer (CRC) is a common health issue worldwide with an extremely low survival
rate after relapse. This study aims to evaluate the immunohistochemical expression of p53 …

Background: A variety of colorectal lesions are surgically treated encompassing both benign
and malignant polyps and colorectal cancer (CRC). CRC is the third most common cause of …

Background & Objective: The current approaches to reduce the risk of colorectal carcinoma
are through the detection and removal of the precursor lesion” adenomatous polyps”. The …

Objective: Tumor grade employed for colorectal cancer has long been based on the degree
of differentiation, which is difficult to judge objectively. The aim of this study was to assess …